A team of University of Michigan researchers, led by Sriram Chandrasekaran, Associate Professor, Biomedical Engineering, and postdoctoral fellow Awanti Sambarey developed a multimodal AI model to predict treatment outcomes of tuberculosis (TB) patients. Their analysis of real-world worldwide patient data may lead to personalization of TB treatment. 

The World Health Organization (WHO) is in the process of updating high-priority Target Product Profiles (TPPs) for TB screening tests.

Tuberculosis, the main cause of death due to a single pathogen globally, causes more than 1.5 million deaths each year. New research from the University of Cincinnati finds that being in prison or being a former prisoner is responsible for high rates of multidrug-resistant (MDR) TB.

CD4⁺ T cells have been highlighted in the scientific literature for the important role they play in the immune response to lung infections. However, an article published in the journal Cell Reports shows that an imbalance in the volumes of these defense cells in different parts of the lung in response to infection can do more harm than good.

What telltale features—many inaudible to the human ear—separate one kind of cough from another? Scientists are on the verge of finding out with a new machine learning tool aimed at identifying the signature sounds of tuberculosis.

LA JOLLA, CA, February 6, 2024 — La Jolla Institute for Immunology (LJI) is working to guide the development of new tuberculosis vaccines and drug therapies. 

The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union).

Despite a decline for almost 30 years, tuberculosis (TB) cases have increased recently, with 8,300 patients in the U.S. testing positive for the disease in 2022, according to CDC data. Artificial intelligence (AI) aims to turn the tide, with a new application earning breakthrough designation from the U.S. Food and Drug Administration’s (FDA) Center for Devices and Radiological Health.

The patent opposition was submitted by the Indonesia AIDS Coalition and Indonesia for Global Justice in November 2022 and was rejected by a decision from the Judiciary Panel on 9 November 2023.

The Office of HIV/AIDS Network Coordination (HANC) and the TB Trials Consortium Community Research Advisors Group will host a webinar on 22 February 2024 focused on TB vaccines.